Earth Science Tech (ETST) Other Operating Expenses (2011 - 2026)
Earth Science Tech (ETST) posted Other Operating Expenses of $4.3 million for Q1 2026, up 4.04% on a QoQ basis from $4.1 million in Q4 2025, and down 4.83% year-over-year from $4.5 million in Q1 2025.
Earth Science Tech (ETST) Other Operating Expenses (2011 - 2026) Analysis & Trends
Earth Science Tech's Other Operating Expenses history runs 15 years deep, the most recent figure standing at $4.3 million for Q1 2026.
- Quarterly Other Operating Expenses fell 4.83% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.5 million (up 2.84% YoY) and the FY2026 annual result came in at $18.5 million, up 10.92% from the prior year.
- Other Operating Expenses was $4.3 million for Q1 2026 at Earth Science Tech, up from $4.1 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $5.7 million in Q1 2024 and bottomed at $36080.0 in Q1 2022.
- A 5-year average of $2.6 million and a median of $4.0 million in 2024 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses plunged 73.34% — and 2024, when it jumped 13040.43%.
- Earth Science Tech's Other Operating Expenses stood at $44384.0 in 2022, then surged by 1362.15% to $648959.0 in 2023, then soared by 522.59% to $4.0 million in 2024, then grew by 1.68% to $4.1 million in 2025, then increased by 4.04% to $4.3 million in 2026.
- Business Quant data shows ETST's Other Operating Expenses at $4.3 million in Q1 2026, $4.1 million in Q4 2025, and $5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.27 Mn |
| Dec 31, 2025 | 4.11 Mn |
| Sep 30, 2025 | 5.25 Mn |
| Jun 30, 2025 | 4.87 Mn |
| Mar 31, 2025 | 4.49 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 4.18 Mn |
| Jun 30, 2024 | 5.28 Mn |
| Mar 31, 2024 | 5.71 Mn |
| Dec 31, 2023 | 648,959.00 |
| Sep 30, 2023 | 607,788.00 |
| Jun 30, 2023 | 40,218.00 |
| Mar 31, 2023 | 69,325.00 |
| Dec 31, 2022 | 44,384.00 |
| Sep 30, 2022 | 63,969.00 |
| Jun 30, 2022 | 36,450.00 |
| Mar 31, 2022 | 36,080.00 |
| Jun 30, 2021 | -1,712.00 |
| Mar 31, 2021 | 135,350.00 |
| Dec 31, 2020 | 58,548.00 |